2017 Avian Influenza A(H7N9) Virus Outbreak And Vaccine Development by Hualan
2017 Avian Influenza A (H7N9) Virus Outbreak refers to the Avian Influenza A (H7N9) Virus happened in 2017. Each year, from December and March of the year, there is a high incidence of avian influenza, and the positive rate of the poultry market is higher than the normal period.
H7N9 is a subtype of avian influenza. The outside of influenza virus is covered by two types surface glycoprotein, one is the phytohemagglutinin ( H ), the other is neuraminidase ( N ), H is divided into 15 subtypes, and N is divided into 9 subtypes. All the human influenza viruses can cause avian influenza, but not all of the avian influenza viruses can cause human influenza. Among the avian influenza virus, H5, H7 and H9 can be transmitted to people, while H5 has high pathogenicity. According to the characteristics of influenza virus, there are 135 types of HxNx, and the H7N9 subtype avian influenza virus is one of them.
H7N9 Influenza Vaccine Development
Hualan Biological Bacterin Co., Ltd, the subsidiary of Hualan Biological Engineering Inc., got H7N9 influenza vaccine strain for research and development from WHO accredited laboratory on May 27, 2013, and started the development officially.
TAG:  H7N9 Influenza Vaccine, Hualan Biological